These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
692 related items for PubMed ID: 18069755
21. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications. Zhang C, Li H, Wang Y, Liu W, Zhang Q, Zhang T, Zhang X, Han B, Zhou G. J Hepatol; 2010 Nov; 53(5):889-95. PubMed ID: 20675009 [Abstract] [Full Text] [Related]
22. Silencing of ATP4B of ATPase H+/K+ Transporting Beta Subunit by Intragenic Epigenetic Alteration in Human Gastric Cancer Cells. Lin S, Lin B, Wang X, Pan Y, Xu Q, He JS, Gong W, Xing R, He Y, Guo L, Lu Y, Wang JM, Huang J. Oncol Res; 2017 Mar 13; 25(3):317-329. PubMed ID: 28281974 [Abstract] [Full Text] [Related]
23. Effect of trichostatin A and 5-Aza-2'-deoxycytidine on transgene reactivation and epigenetic modification in transgenic pig fibroblast cells. Kong Q, Wu M, Wang Z, Zhang X, Li L, Liu X, Mu Y, Liu Z. Mol Cell Biochem; 2011 Sep 13; 355(1-2):157-65. PubMed ID: 21541675 [Abstract] [Full Text] [Related]
24. Role of histone modifications and DNA methylation in the regulation of O6-methylguanine-DNA methyltransferase gene expression in human stomach cancer cells. Meng CF, Zhu XJ, Peng G, Dai DQ. Cancer Invest; 2010 May 13; 28(4):331-9. PubMed ID: 19857042 [Abstract] [Full Text] [Related]
25. 5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation. Wozniak RJ, Klimecki WT, Lau SS, Feinstein Y, Futscher BW. Oncogene; 2007 Jan 04; 26(1):77-90. PubMed ID: 16799634 [Abstract] [Full Text] [Related]
26. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines. Osada H, Tatematsu Y, Sugito N, Horio Y, Takahashi T. Mol Carcinog; 2005 Dec 04; 44(4):233-41. PubMed ID: 16163707 [Abstract] [Full Text] [Related]
27. Genome-wide analysis of histone modifications by ChIP-chip to identify silenced genes in gastric cancer. Zhu X, Liu J, Xu X, Zhang C, Dai D. Oncol Rep; 2015 May 04; 33(5):2567-74. PubMed ID: 25738530 [Abstract] [Full Text] [Related]
28. Long term transcriptional reactivation of epigenetically silenced genes in colorectal cancer cells requires DNA hypomethylation and histone acetylation. Mossman D, Scott RJ. PLoS One; 2011 May 04; 6(8):e23127. PubMed ID: 21829702 [Abstract] [Full Text] [Related]
29. [Correlation between histone H3-K9 methylation, DNA methylation and expression of gene MGMT in Hep-2 cell line]. Yang J, He L, Ji W, Jin M, Zhao X. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Nov 04; 26(21):984-7. PubMed ID: 23373238 [Abstract] [Full Text] [Related]
30. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Kawamoto K, Hirata H, Kikuno N, Tanaka Y, Nakagawa M, Dahiya R. Int J Cancer; 2008 Aug 01; 123(3):535-42. PubMed ID: 18404682 [Abstract] [Full Text] [Related]
31. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Zhang Y, Fatima N, Dufau ML. Mol Cell Biol; 2005 Sep 01; 25(18):7929-39. PubMed ID: 16135786 [Abstract] [Full Text] [Related]
32. Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins. Danam RP, Howell SR, Brent TP, Harris LC. Mol Cancer Ther; 2005 Jan 01; 4(1):61-9. PubMed ID: 15657354 [Abstract] [Full Text] [Related]
33. The histone code regulating expression of the imprinted mouse Igf2r gene. Yang Y, Li T, Vu TH, Ulaner GA, Hu JF, Hoffman AR. Endocrinology; 2003 Dec 01; 144(12):5658-70. PubMed ID: 12975326 [Abstract] [Full Text] [Related]
34. Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation. Zhang YW, Staal B, Dykema KJ, Furge KA, Vande Woude GF. PLoS One; 2012 Dec 01; 7(6):e38955. PubMed ID: 22701735 [Abstract] [Full Text] [Related]
35. Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation. Coombes MM, Briggs KL, Bone JR, Clayman GL, El-Naggar AK, Dent SY. Oncogene; 2003 Dec 04; 22(55):8902-11. PubMed ID: 14654786 [Abstract] [Full Text] [Related]
36. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma. Li Z, Zhang H, Yang J, Hao T, Li S. Cell Biol Int; 2012 May 01; 36(5):427-32. PubMed ID: 21864295 [Abstract] [Full Text] [Related]
37. Analysis of specific lysine histone H3 and H4 acetylation and methylation status in clones of cells with a gene silenced by nickel exposure. Yan Y, Kluz T, Zhang P, Chen HB, Costa M. Toxicol Appl Pharmacol; 2003 Aug 01; 190(3):272-7. PubMed ID: 12902198 [Abstract] [Full Text] [Related]
38. [Expression of neprilysin gene is associated with methylation and histone modification on promoter in mouse neuroblastoma Neuro-2a cells]. Deng Y, Lu X, Liu L, Li T, Zhang Y, Guo X, Yu G. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug 01; 30(8):810-3. PubMed ID: 25108432 [Abstract] [Full Text] [Related]
39. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island. Zhao W, Soejima H, Higashimoto K, Nakagawachi T, Urano T, Kudo S, Matsukura S, Matsuo S, Joh K, Mukai T. J Biochem; 2005 Mar 01; 137(3):431-40. PubMed ID: 15809347 [Abstract] [Full Text] [Related]
40. Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments. Tabolacci E, Pietrobono R, Moscato U, Oostra BA, Chiurazzi P, Neri G. Eur J Hum Genet; 2005 May 01; 13(5):641-8. PubMed ID: 15741991 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]